Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents

Area of Science:

• Mycology
• Infectious Diseases
• Pharmacology

Background:

• Fungal infections cause significant global morbidity and mortality.
• Limited antifungal agents and increasing drug resistance necessitate new therapeutic strategies.
• The fungal cell wall is a critical target for antifungal drug development due to its essential role in fungal survival.

Purpose of the Study:

• To review current antifungal cell wall inhibitors.
• To identify promising drug candidates for treating fungal infections.
• To highlight future research directions for antifungal drug discovery targeting the fungal cell wall.

Main Methods:

• Literature review of existing antifungal cell wall inhibitors.
• Analysis of current drug candidates targeting the fungal cell wall.
• Exploration of compounds with detrimental effects on the fungal cell wall structure.

Main Results:

• Several classes of cell wall inhibitors are currently available.
• Emerging drug resistance is a significant challenge for existing antifungal therapies.
• New drug candidates targeting the fungal cell wall show potential for treating resistant infections.

Conclusions:

• The fungal cell wall remains a vital target for developing novel antifungal agents.
• Further research into compounds affecting the fungal cell wall is crucial for addressing unmet clinical needs.
• Development of alternative cell wall inhibitors is essential to combat difficult-to-treat fungal infections and overcome resistance.